Advertisement
Screener

BIOMERICA INC (BMRA) EBITDA

BIOMERICA INC (BMRA) EBITDA

  • 2026-02-28: Basis Reported; EBITDA (m); Operating income -$1.30M; Depreciation and amortization (m).
  • 2025-11-30: Basis Reported; EBITDA (m); Operating income -$1.37M; Depreciation and amortization (m).
  • 2025-08-31: Basis Reported; EBITDA (m); Operating income -$1.12M; Depreciation and amortization (m).
  • 2025-02-28: Basis Reported; EBITDA (m); Operating income -$1.21M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2011-05-31 to 2023-08-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-02-28Reported(m)-$1.30M(m)$987.00K(m)(m)-$1.25M*(m)$178.00K$1.08M$8.00K
2025-11-30Reported(m)-$1.37M(m)$1.21M(m)(m)-$991.00K*(m)$193.00K$1.23M$5.00K
2025-08-31Reported(m)-$1.12M(m)$1.38M(m)(m)-$268.00K(m)$212.00K$1.33M$3.00K
2025-02-28Reported(m)-$1.21M(m)$1.12M(m)(m)-$1.04M*(m)$217.00K$1.01M-$4.00K
2024-11-30Reported(m)-$993.00K(m)$1.64M(m)(m)-$791.00K*(m)$257.00K$1.17M-$3.00K
2024-08-31Reported(m)-$1.37M(m)$1.81M(m)(m)-$1.34M(m)$297.00K$1.36M$4.00K
2024-02-29Reported(m)-$2.00M(m)$1.02M(m)$0.00*-$1.80M*(m)$343.00K$1.51M$4.00K
2023-11-30Reported(m)-$1.61M(m)$1.57M(m)$6.00K*-$842.00K*(m)$412.00K$1.52M$8.00K
2023-08-31Reported-$1.21M(m)(m)(m)-70.69%$21.00K-$1.67M(m)$472.00K$1.17M$23.00K
2023-05-31Reported-$1.8M(m)(m)(m)-162.73%(m)(m)(m)(m)(m)(m)
2023-02-28Reported-$1.64M(m)(m)(m)-147.25%$6.00K*-$1.73M*(m)$392.00K$1.38M$35.00K
2022-11-30Reported-$1.65M(m)(m)(m)-111.34%$24.00K*-$1.21M*(m)$462.00K$1.56M$1.00K
2022-08-31Reported-$2.04M(m)(m)(m)-124.68%$34.00K-$1.57M(m)$361.00K$1.65M$2.00K
2022-05-31Reported-$1.5M(m)(m)(m)-28.24%(m)(m)(m)(m)(m)(m)
2022-02-28Reported-$81,499.00(m)(m)(m)-1.06%$14.34K*$2.36M*(m)$387.10K$1.39M$2.69K
2021-11-30Reported-$1.1M(m)(m)(m)-23.75%$13.07K*$1.34M*(m)$547.93K$1.35M$2.43K
2021-08-31Reported-$1.51M(m)(m)(m)-119.84%$5.14K$75.84K(m)$381.54K$1.07M$9.02K
2021-05-31Reported-$1.7M(m)(m)(m)-160.84%(m)(m)(m)(m)(m)(m)
2021-02-28Reported-$2.14M(m)(m)(m)-58.95%$45.19K*-$1.36M*(m)$563.97K$1.53M-$3.12K
2020-11-30Reported-$1.69M(m)(m)(m)-122.85%$21.98K*-$1.28M*(m)$616.56K$1.40M$13.39K
2020-08-31Reported-$1.87M(m)(m)(m)-163.69%$39.59K-$1.60M(m)$711.50K$1.31M$1.13K
2020-05-31Reported-$460,203.00(m)(m)(m)-16.89%(m)(m)(m)(m)(m)(m)
2020-02-29Reported-$891,063.00(m)(m)(m)-75.71%$21.40K*-$436.92K*(m)$473.28K$653.59K(m)
2019-11-30Reported-$465,422.00(m)(m)(m)-29.15%$4.15K*-$357.84K*(m)$404.85K$553.76K(m)
2019-08-31Reported-$480,061.00(m)(m)(m)-40.19%$2.17K-$8.15K(m)$370.47K$506.40K$800.00
2019-05-31Reported-$741,721.00(m)(m)(m)-63.63%(m)(m)(m)(m)(m)(m)
2019-02-28Reported-$684,812.00(m)(m)(m)-54.31%$19.87K*-$256.64K*(m)$497.10K$576.07K(m)
2018-11-30Reported-$457,550.00(m)(m)(m)-30.49%$15.00K*-$244.41K*(m)$381.40K$512.59K(m)
2018-08-31Reported-$427,491.00(m)(m)(m)-33.58%$38.08K-$756.66K(m)$391.78K$400.23K(m)
2018-05-31Reported-$620,567.00(m)(m)(m)-54.90%(m)(m)(m)(m)(m)(m)
2018-02-28Reported-$294,502.00(m)(m)(m)-21.41%$21.38K*-$488.82K*(m)$353.56K$434.66K(m)
2017-11-30Reported-$260,825.00(m)(m)(m)-16.16%$32.95K*-$238.64K*(m)$272.44K$522.49K(m)
2017-08-31Reported-$194,806.00(m)(m)(m)-13.49%$19.97K-$124.71K(m)$288.58K$452.01K(m)
2017-05-31Reported-$314,721.00(m)(m)(m)-21.71%(m)(m)(m)(m)(m)(m)
2017-02-28Reported-$284,034.00(m)(m)(m)-18.94%$70.15K*-$81.49K*(m)$256.72K$510.43K(m)
2016-11-30Reported-$182,035.00(m)(m)(m)-12.71%(m)-$235.96K*(m)$300.96K$475.26K(m)
2016-08-31Reported-$28,661.00(m)(m)(m)-2.03%(m)-$71.93K(m)$224.25K$418.35K(m)
2016-05-31Reported-$232,784.00(m)(m)(m)-17.55%(m)(m)(m)(m)(m)(m)
2016-02-29Reported-$230,738.00(m)(m)(m)-16.95%$41.70K*$229.99K*(m)$185.27K$428.36K-$125.00K
2015-11-30Reported-$171,065.00(m)(m)(m)-14.68%$22.61K*-$229.40K*(m)$230.21K$391.60K-$129.00K
2015-08-31Reported-$36,082.00(m)(m)(m)-2.80%$5.68K-$195.64K(m)$157.99K$339.66K(m)
2015-05-31Reported-$19,206.00(m)(m)(m)-1.28%(m)(m)(m)(m)(m)(m)
2015-02-28Reported-$88,718.00(m)(m)(m)-6.83%$2.00*-$502.91K*(m)$184.63K$409.74K-$16.62K
2014-11-30Reported-$205,589.00(m)(m)(m)-18.14%$4.98K*$40.35K*(m)$182.09K$375.02K(m)
2014-08-31Reported-$178,871.00(m)(m)(m)-17.29%$3.67K$143.64K(m)$195.71K$338.32K(m)
2014-05-31Reported-$11,992.00(m)(m)(m)-0.71%(m)(m)(m)(m)(m)(m)
2014-02-28Reported$77,900.00(m)(m)(m)5.22%$33.51K*-$112.75K*(m)$140.18K$405.77K$9.54K
2013-11-30Reported-$204,050.00(m)(m)(m)-21.83%$75.12K*-$363.88K*(m)$136.79K$366.36K(m)
2013-08-31Reported-$130,989.00(m)(m)(m)-12.92%$8.73K-$376.27K(m)$91.26K$342.80K(m)
2013-05-31Reported$62,537.00(m)(m)(m)4.25%(m)(m)(m)(m)(m)(m)
2013-02-28Reported-$14,113.00(m)(m)(m)-1.00%$6.99K*$1.10M*(m)$150.18K$358.53K-$20.64K
2012-11-30Reported$312,937.00(m)(m)(m)16.61%$177.23K*$66.59K*(m)$115.74K$405.97K$11.71K
2012-08-31Reported$357,538.00(m)(m)(m)21.01%$65.19K$330.40K(m)$87.98K$332.13K$21.32K
2012-05-31Reported$101,065.00(m)(m)(m)6.55%(m)(m)(m)(m)(m)(m)
2012-02-29Reported$169,049.00(m)(m)(m)11.16%$86.21K*$26.84K*(m)$94.77K$337.58K$25.57K
2011-11-30Reported$237,708.00(m)(m)(m)14.70%$9.85K*-$31.73K*(m)$85.55K$387.77K(m)
2011-08-31Reported$152,836.00(m)(m)(m)10.86%$39.47K$108.02K(m)$85.94K$313.58K(m)
2011-02-28Reported(m)$73.02K(m)(m)(m)$19.63K*-$11.68K*(m)$97.01K$329.46K$0.00
2010-11-30Reported(m)-$177.62K(m)(m)(m)$57.49K*$276.72K*(m)$120.12K$358.04K(m)
2010-08-31Reported(m)-$12.23K(m)(m)(m)$6.58K-$199.15K(m)$97.85K$303.16K(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-05-31Reported(m)-$5.32M(m)$4.45M(m)(m)-$3.42M(m)$788.00K$4.89M$23.00K
2025-05-31Reported(m)-$5.14M(m)$5.31M(m)(m)-$3.84M(m)$1.02M$4.61M$1.00K
2024-05-31Reported(m)-$6.37M(m)$5.42M(m)$51.00K-$5.36M(m)$1.49M$5.49M$42.00K
2023-05-31Reported-$7.14M(m)(m)(m)-133.71%$64.00K-$5.47M(m)$1.58M$6.08M$51.00K
2022-05-31Reported-$4.2M(m)(m)(m)-22.23%$57.00K-$479.00K(m)$1.81M$5.70M$24.00K
2021-05-31Reported-$7.39M(m)(m)(m)-102.72%$135.86K-$5.25M(m)$2.19M$5.67M$13.06K
2020-05-31Reported-$2.3M(m)(m)(m)-34.33%$33.61K-$4.30M(m)$1.93M$2.55M$7.39K
2019-05-31Reported-$2.31M(m)(m)(m)-44.45%$101.14K-$2.24M(m)$1.68M$2.03M$24.24K
2018-05-31Reported-$1.37M(m)(m)(m)-24.63%$130.35K-$1.17M(m)$1.40M$1.84M$31.80K
2017-05-31Reported-$809,746.00(m)(m)(m)-13.98%$96.08K-$722.86K(m)$1.13M$1.85M(m)
2016-05-31Reported-$670,669.00(m)(m)(m)-13.05%$91.56K-$208.78K(m)$780.33K$1.57M$703.80K
2015-05-31Reported-$492,376.00(m)(m)(m)-9.92%$10.50K-$405.48K(m)$733.64K$1.48M-$315.02K
2014-05-31Reported-$269,076.00(m)(m)(m)-5.25%$137.23K-$862.27K(m)$589.87K$1.53M-$210.76K
2013-05-31Reported$701,333.00(m)(m)(m)10.83%$257.12K$1.39M(m)$459.09K$1.45M-$12.49K
2012-05-31Reported$652,296.00(m)(m)(m)10.73%$164.80K$147.41K(m)$347.13K$1.45M$65.01K
2011-05-31Reported-$2,215.00(m)(m)(m)-0.05%$141.08K$328.80K(m)$420.57K$1.24M$2.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92